ClearSign Technologies Corporation — Q1 2024 10-Q
Business and period: Unaudited results for the three months ended March 31, 2024, compared with Q1 2023. ClearSign develops combustion and fuel-safety technologies, including low-emissions burner products. Revenue was primarily from process burners, related services, engineering work and spare parts.
Financial results
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $1.102 million | $894,000 | +23.3% |
| Gross profit / margin | $437,000 / 39.7% | $106,000 / 11.9% | Gross profit +$331,000 |
| Operating expenses | $1.689 million | $1.810 million | -6.7% |
| Operating loss | $1.252 million | $1.704 million | Improved $452,000 |
| Other income | $144,000 | $275,000 | -47.7% |
| Net loss / loss per share | $1.108 million / $0.03 | $1.429 million / $0.04 | Loss improved $321,000 |
| Operating cash flow | $(1.001) million | $(554,000) | Cash use increased |
Cash and cash equivalents were $4.624 million at March 31, down $1.060 million from year-end. Working capital was $3.540 million, versus $4.253 million at December 31, 2023. Investing cash use was $34,000 and financing cash use was $22,000. The company reported no contractual debt obligations; lease liabilities totaled $223,000, including $66,000 current and $157,000 long term.
Changes, liquidity and outlook
- Gross profit increased substantially as Q1 2024 included higher-margin process-burner shipments; management noted customer witness tests typically have lower margins.
- R&D expense rose 75.7% to $281,000, mainly due to additional headcount and related benefits. G&A fell 14.7% to $1.408 million, partly because the prior-year quarter included $187,000 of RSU expense triggered by a board member’s departure.
- Other income declined mainly because Q1 2023 included $119,000 from sale of materials during the Seattle office decommissioning.
- Management expects operating losses and negative cash flow for the foreseeable future and says meaningful growth depends on market acceptance, recurring sales and continued access to funding. No specific revenue or earnings guidance is provided.
- The 2023 Form 10-K audit report raised substantial doubt about the company’s ability to continue as a going concern. Management said subsequent equity financings alleviated that doubt and that, considering those financings and expected collections, cash should fund current operating expenses for over 12 months.
- After quarter-end, the April public offering and concurrent private placement, followed by the May 15 over-allotment, generated approximately $9.9 million gross and $8.7 million net proceeds. The transactions included common shares and substantial warrant issuance, creating dilution and potential future dilution.
Risks, contingencies and other notable items
- Nasdaq notified the company on May 2, 2024 that it failed the $1 minimum bid-price requirement. It has until October 29, 2024 to regain compliance; failure could lead to delisting and impair access to capital.
- The company says it may not have enough authorized, unissued common shares to reserve for private warrants. It is seeking stockholder approval to increase authorized common shares from 62.5 million to 87.5 million; approval is not assured.
- The ATM program was suspended on March 18, 2024. Baby-shelf restrictions may constrain future securities sales.
- Key disclosed risks include limited operating history and cash, continued losses, commercialization and customer-acceptance uncertainty, competition, financing access, intellectual-property protection, China-related risks, and potential Nasdaq listing issues.
- No material pending legal proceedings were reported. Management concluded disclosure controls were effective as of March 31, 2024; no material change in internal control was reported.
Important facts for investors to verify
- Cash runway assumptions and whether operating cash use, customer collections and commercialization progress support management’s over-12-month liquidity assessment.
- Shareholder approval of the proposed authorized-share increase and the company’s ability to reserve and deliver shares underlying warrants.
- Progress toward Nasdaq’s bid-price compliance deadline and any effect on listing status or financing options.
- Actual dilution from issued shares, pre-funded warrants, public and private warrants, and underwriter and placement-agent warrants.
- Whether higher revenue and gross margins can persist, given quarterly project timing and the concentration of reported revenue in process-burner activity.